Survival Benefit of Adding Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) at the Different Time-points of Treatment of Ovarian Cancer: Review of Evidence

Publisher: Bentham Science Publishers

E-ISSN: 1873-4286|18|25|3793-3803

ISSN: 1381-6128

Source: Current Pharmaceutical Design, Vol.18, Iss.25, 2012-07, pp. : 3793-3803

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content